Aurelien Amiot - Publications

Real world experience with granulocyte and monocyte adsorptive apheresis (ADACOLUMN®) in patients with refractory inflammatory bowel disease: a retrospective observational multicenter cohort study.

Journal: Clinics and research in hepatology and gastroenterology

Published: May 28, 2026

Comparative risk of serious infection in patients with ulcerative colitis treated with JAK inhibitors.

Journal: Journal of Crohn's & colitis

Published: May 12, 2026

Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID.

Journal: Clinics and research in hepatology and gastroenterology

Published: May 08, 2026

One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study.

Journal: Alimentary pharmacology & therapeutics

Published: February 17, 2026

Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 30, 2025

Histogenetic Classification Predicts Outcomes in 130 Adults with Chronic Intestinal Pseudo-Obstruction.

Journal: The American journal of gastroenterology

Published: October 27, 2025

Expert opinion on hot topics in the field of IBD.

Journal: Clinics and research in hepatology and gastroenterology

Published: October 27, 2025

Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.

Journal: Clinics and research in hepatology and gastroenterology

Published: October 27, 2025

IBD in transition, progresses and challenges.

Journal: Clinics and research in hepatology and gastroenterology

Published: October 22, 2025

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Journal: United European gastroenterology journal

Published: October 19, 2025

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Journal: United European gastroenterology journal

Published: October 19, 2025

Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 07, 2025